Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina

Journal of Medical Virology

Volumn 79, Issue 1, 2007, Pages 69-73

  Berini, Carolina A ^a   Eirin, Maria E ^a   Pando, Maria A ^a   Biglione, Mirna M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Blood donors; FSW; HSH; HTLV; IDU; Indeterminate

Indexed keywords

GAG PROTEIN; GENE PRODUCT; PROTOZOON ANTIBODY; VIRUS ENVELOPE PROTEIN;

ARGENTINA; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; ENVELOPE GENE; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GROUP SPECIFIC ANTIGEN GENE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; RETROVIRUS; STRUCTURAL GENE; TAX GENE; TRYPANOSOMA CRUZI; VIRUS GENE; VIRUS INFECTION; WESTERN BLOTTING;

ARGENTINA; BLOTTING, WESTERN; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS;

HUMAN T-LYMPHOTROPIC VIRUS 1; TRYPANOSOMA CRUZI;

EID: 33845396426     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20731     Document Type: Article

References (28)

1. Biglione M, Pizarro M, Crespo O, Severich I, Martinez Peralta L, Libonatti O, Mercedes Avila M, Astarloa L. 1999. High prevalence of HTLV-I infection in Argentinian blood donors: A new HTLV-I-endemic area? J Acquir Immune Defic Syndr Hum Retrovirol 20:101-102.
2. Bouzas MB, Muchinik G, Zapiola I, De Rosa MF, Perez Bianco R, Cahn P, Gallo D, Hanson C. 1991. Human T cell lymphotropic virus Type II infection in Argentina. J Infect Dis 164:1026-1027.
3. Busch MP, Switzer WM, Murphy EL, Thomson R, Heneine W. 2000. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Transfusion 40:443-449.
4. Centers for Disease Control and Prevention and U.S. Public Health Service Working Group. 1993. Recommendations for counseling persons infected with human T-lymphotrophic virus, Types I and II. MMWR Recomm Rep 42:1-13.
5. d'Auriol L, Vernant JC, Ouka M, Nerienet E, Buisson G, Neisson-Vernant C, Galibert F, Monplaisir N. 1990. Diagnosis of HTLV-I infected seronegative neurological patients by polymerase chain reaction amplification in Martinique. Nouv Rev Fr Hematol 32:113-116.
6. Dipierri JE, Tajima K, Cartier Robirosa L, Sonoda S. 1999. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujena. Medicina (B Aires) 59:717-720.
7. Gessain A, Mathieux R. 1995. HTLV-I "indeterminate" Western blot patterns observed in sera from tropical regions: The situation revisited. J Acquir Immune Defic Syndr Hum Retrovirol 9:316-319.
8. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. 1985. Antibodies to human T-lymphotropic virus Type-I in patients with tropical spastic paraparesis. Lancet 2:407-410.
9. Heneine W, Khabbaz RF, Lal RB, Kaplan JE. 1992. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus Typel (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals. J Clin Microbiol 30:1605-1607.
10. Khabbaz RF, Heneine W, Grindon A, Hartley TM, Shulman G, Kaplan J. 1992. Indeterminate HTLV serologic results in U.S. blood donors: Are they due to HTLV-I or HTLV-II? J Acquir Immune Defic Syndr 5:400-404.
11. Kwok S, Lipka JJ, McKinney N, Kellogg DE, Poiesz B, Foung SK, Sninsky JJ. 1990. Low incidence of HTLV infections in random blood donors with indeterminate Western blot patterns. Transfusion 30:491-494.
12. Lu SC, Chen BH. 2003. Seroindeterminate HTLV-1 prevalence and characteristics in blood donors in Taiwan. Int J Hematol 77:412-413.
13. Mahieux R, Pecon-Slattery J, Chen GM, Gessain A. 1998. Evolutionary inferences of novel simian T lymphotropic virus Type 1 from wild-caught chacma (Papio ursinus) and olive baboons (Papio anubis). Virology 251:71-84.
14. Mahieux R, Horal P, Mauclere P, Mercereau-Puijalon O, Guillotte M, Meertens L, Murphy E, Gessain A. 2000. Human T-cell lymphotropic virus Type 1 gag indeterminate Western blot patterns in Central Africa: Relationship to Plasmodium falciparum infection. J Clin Microbiol 38:4049-4057.
15. Mangano AM, Remesar M, del Pozo A, Sen L. 2004. Human T lymphotropic virus Types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. J Med Virol 74:323-327.
16. Mueller N. 1991. The epidemiology of HTLV-I infection. Cancer Causes Control 2:37-52.
17. Pando Mde L, Maulen S, Weissenbacher M, Marone R, Duranti R, Peralta LM, Salomon H, Russell K, Negrete M, Estani SS, Montano S, Sanchez JL, Avila MM. 2003. High human immunodeficiency virus Type 1 seroprevalence in men who have sex with men in Buenos Aires, Argentina: Risk factors for infection. Int J Epidemiol 32:735-740.
18. Pando MA, De Salvo C, Feola M, Lado I, Hoffman M, Schvachsa N, Sánchez JL, Weissenbacher M. 2004. Blood borne and Sexually-Transmitted Infections (STI) in Patients Infected with Mycobacterium tuberculosis (Tb) in Argentina. XV International AIDS Conference Bangkok, Thailand. p150.
19. Pando MA, Berini C, Bibini M, Fernandez M, Reinaga E, Maulen S, Marone R, Biglione M, Montano SM, Bautista CT, Weissenbacher M, Sanchez JL, Avila MM. 2006. Prevalence of HIV and other sexually transmitted infections among female commercial sex workers in Argentina. Am J Trop Med Hyg 74:233-238.
20. Prince HE, Gross M. 2001. Impact of initial screening for human T-cell lymphotropic virus (HTLV) antibodies on efficiency of HTLV Western blotting. Clin Diagn Lab Immunol 8:467.
21. Rouet F, Meertens L, Courouble G, Herrmann-Storck C, Pabingui R, Chancerel B, Abid A, Strobel M, Mauclere P, Gessain A. 2001. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean. J Clin Microbiol 39:1247-1253.
22. Santos Tde J, Costa CM, Goubau P, Vandamme AM, Desmyter J, Van Doren S, Mota RM, de Castro Costa FB, Oliveira AC, Barreto V, Gomes AF, Carneiro-Proietti AB, de Bruin VM, de Sousa FC, Oria RB. 2003. Western blot seroindeterminate individuals for human T-lymphotropic virus I/II (HTLV-I/II) in Fortaleza (Brazil): A serological and molecular diagnostic and epidemiological approach. Braz J Infect Dis 7:202-209.
23. Tuke PW, Luton P, Garson JA. 1992. Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of 'nested' PCR products. J Virol Methods 40:163-173.
24. Vandamme AM, Van Laethem K, Liu HF, Van Brussel M, Delaporte E, de Castro Costa CM, Fleischer C, Taylor G, Bertazzoni U, Desmyter J, Goubau P. 1997. Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) Types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology. J Med Virol 52:1-7.
25. Vrielink H, Reesink HW. 2004. HTLV-I/II prevalence in different geographic locations. Transfus Med Rev 18:46-57.
26. Waziri A, Soldan SS, Graf MD, Nagle J, Jacobson S. 2000. Characterization and sequencing of prototypic human T-lymphotropic virus Type 1 (HTLV-1) from an HTLV-1/2 seroindeterminate patient. J Virol 74:2178-2185.
27. Weissenbacher M, Rossi D, Radulich G, Sosa-Estani S, Vila M, Vivas E, Avila MM, Cuchi P, Rey J, Peralta LM. 2003. High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina. Clin Infect Dis 37:3348-352.
28. Yoshida M, Miyoshi I, Hinuma Y. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031-2035.